This bill requires an interagency review to identify opportunities for accelerating lung cancer research in women and underserved populations, improving access to preventive services, and creating public awareness campaigns.
Tina Smith
Senator
MN
The "Women and Lung Cancer Research and Preventive Services Act of 2025" mandates an interagency review led by the Department of Health and Human Services to identify opportunities for accelerating lung cancer research in women and underserved populations, improving access to preventive services, and developing strategic public awareness campaigns. This review will assess past research, identify knowledge gaps, and explore collaborative research opportunities. A report summarizing the review's findings and recommendations must be submitted to Congress within two years.
This legislation, the "Women and Lung Cancer Research and Preventive Services Act of 2025," directs top federal health agencies to take a hard look at how the U.S. handles lung cancer, particularly concerning women and underserved communities.
The core of this bill is ordering an interagency review. Think of it as the federal government hitting pause to figure out what's working, what's not, and where the gaps are in lung cancer research and care. The Secretary of Health and Human Services (HHS) will lead the charge, teaming up with the Departments of Defense (DoD) and Veterans Affairs (VA). Their mission, as laid out in Section 2, is to evaluate current efforts and pinpoint opportunities across the board.
They've got two years from the bill's enactment to report back to Congress. This report isn't just a status update; it's meant to be a roadmap. It needs to cover past research findings, what studies are happening now, and crucially, identify the blind spots in our knowledge, especially regarding women and populations who meet screening criteria but face barriers to care.
The review has specific homework assignments outlined in Section 2. It needs to identify ways to:
Essentially, this bill aims to gather the necessary intelligence to potentially launch more effective, targeted strategies against lung cancer in the future. It's about laying the groundwork by thoroughly assessing the current landscape and identifying specific pathways for improvement in research, access to preventive services, and public education.